Apellis Pharmaceuticals sell Lokrim
Start price
07.08.23
/
20%
€18.20
Target price
07.08.24
-
Performance (%)
224.18%
End price
19.01.24
€59.00
Summary
This prediction ended on 19.01.24 with a price of €59.00. The price for Apellis Pharmaceuticals massively increased, which is bad news for the SELL prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
According to Lokrim what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Sell Apellis Pharmaceuticals
In the thread Trading Apellis Pharmaceuticals
Sell beendet